Award
Colorado FOIA #1001985506
D-AP5 is a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NM...
Recipient
R&D Systems Inc
Award Amount
$567.00
Ceiling
$567.00
Awarded
May 20, 2024
Identifier
1001985506
Description
D-AP5 is a selective NMDA receptor antagonist that competes with glutamate binding and is commonly used to inhibit NMDA-dependent synaptic plasticity.; SR 95531 hydrobromide__SR 95531 hydrobromide is a selective, competitive GABAA receptor antagonist and allosteric inhibitor (IC50 = 200 nM).